breaking news Biocon Q4 results | Biotech major beats estimates with 31% increase in profits and revenue up 57%
The Board of Directors has recommended a final dividend at the rate of 30% i.e. Rs 1.50 per share with a par value of Rs 5 each for the year ended 31 March 2023. Biocon Ltd shares ended at Rs 241.60, up Rs 1.45, or 0.60 percent on BSE.
Biotech giant Biocon Ltd on Tuesday, May 23, reported a 31.3% year-on-year (YoY) increase in net profit to Rs 313.2 crore for the fourth quarter which ended March 31, 2023 .
In the corresponding quarter of last year, the company recorded a net profit of Rs 238.6 crore. CNBC-TV18 Polls had predicted a profit of Rs 234 crore for the quarter under review.
During the March quarter, total revenue amounted to Rs 3,773.9 crore, up 56.7% from Rs 2,409 crore in the same period last year. CNBC-TV18 Polls had predicted revenue of Rs 3,611.7 crore for the quarter under review.
Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.